Aseptic simulation test for cytotoxic drug production in isolators
Abstract
Purpose The results of a media-fill test (MFT) study to validate processes for cytotoxic drug preparation inside and outside aseptic compounding isolators are presented. Methods Using an MFT protocol adapted to institution-specific production conditions, the pharmacy team at a hospital in France performed a series of tests to verify the efficacy of decontamination and sterile compounding procedures, as required by French compendial standards, while assessing the performance of its team of 12 isolator operators; all operators were tested on three occasions, producing 10 MFT samples per test for a total of 30 samples per operator. The team also tested alternative compounding systems (i.e., two closed-system transfer devices and a classic spike system) for use during power outages or other emergencies precluding drug preparation within isolators. MFTs were performed using a standard tryptone soy broth-based test kit under worst-case conditions. Results The hospital's facilities for cytotoxic drug preparation were found to be in conformance with applicable sterility standards. Bacterial growth was not detected in any of the MFT samples produced by isolator operators during the study (total n = 360). In one instance, an MFT sample prepared using a closed-system transfer device was found to be contaminated due to improper cleaning of the medication vial, highlighting the importance of strict adherence to proper decontamination procedures. Conclusion A hospital's practices for prepa…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Isolator-based platforms reduce supply chain complexity, enhance sterility assurance, and preserve biological integrity of sensitive ATMPs by enabling the entire workflow within a controlled closed environment at or near the bedside.
“By enabling the entire workflow—from tissue acquisition and cell processing to final formulation and reinfusion—to be carried out within a controlled, closed environment at or near the patient’s bedside, isolator-based platforms reduce supply chain complexity, enhance sterility assurance, and preserve the biological integrity of sensitive ATMPs (Savry et al., 2014).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Savry et al., 2014
Cited by
Sorted by citations
Chiu, Y.-S., Wang, K.-L., & Wu, K.-L. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1644318 · Cited by 17 · see citing works
“These challenges are particularly signi fi cant for Advanced Therapy Medicinal Products (ATMPs) (Pharmaceutical Inspection Co-operation Scheme (PIC/S), 2022), which are often administered shortly after culture or thawing and tend to be sensitive to cryopreservation (Meneghel et al., 2020; Joules et al., 2025).”
Influential
- Authors
- Savry, A., Correard, F., Bennis, Y., Roubaud, S., Gauthier-Villano, L., Pisano, P., & Pourroy, B.
- Affiliations
- Hôpital de la Timone (FR)
- Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France.
- Plein Ciel Clinic, Mougins, France.
- Aix-Marseille Université (FR)
- Corresponding author
- Pourroy, Bertrand
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-15
- Volume
- 71
- Issue
- 6
- Pages
- 476-481
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W2328894204
- Cited by
- 11
- References
- 0
- Citations by year
- 2025: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2016: 1
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Health-System Pharmacy (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Health Professions › Occupational Therapy › Safe Handling of Antineoplastic Drugs
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- cytotoxic drugs, aseptic compounding, sterile compounding, decontamination, closed system transfer devices, operator performance, hospital pharmacy, good manufacturing practices
- MeSH terms
- Antineoplastic Agents, Cytotoxins, Drug Compounding, Drug Contamination, Humans, Pharmacy Service, Hospital, Occupational Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review